Analytical Data
-
Gene name
CTSG
- Application
-
Alternative Names
CTSG；Cathepsin G
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P08311
-
Expression Region
21-244aa
-
AA Sequence
IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMRS
-
Molecular Weight
32.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTSG, or Cathepsin G, is a serine protease belonging to the lysosomal cysteine protease family and plays a significant role in various physiological and pathological processes, including immune response and inflammation. Research on CTSG recombinant proteins has gained traction due to their potential applications in therapeutic and diagnostic fields, particularly in understanding diseases associated with excessive neutrophil activation, such as arthritis, asthma, and cancer. By studying the structure and function of CTSG through recombinant DNA technology, scientists can develop targeted inhibitors that modulate its activity, providing insights into its role in disease mechanisms. Furthermore, recombinant CTSG proteins serve as valuable tools in biochemical assays and drug discovery, enabling researchers to investigate protein-protein interactions and cellular pathways involved in inflammation. The interest in CTSG is further fueled by its involvement in the processing of bioactive peptides, which may open new avenues for developing novel therapeutic strategies. Overall, the exploration of CTSG recombinant proteins holds promise not only for advancing our understanding of its biological functions but also for translating this knowledge into innovative medical solutions.
